PLOS 'Q&A' blog post highlights PLOS Medicine series

NewsGuard 100/100 Score

In the latest installment of the PLOS "Speaking of Medicine" blog's Q&A series, Pamela Collins, director of the Office for Research on Disparities and Global Mental Health at the National Institute of Mental Health (NIMH) and "the corresponding author of a series of Policy Forum articles in PLOS Medicine that provides a global perspective on integrating mental health," answers questions "about some of the topics discussed in the new series, which will be published in PLOS Medicine weekly for the next five weeks, starting with the publication [on Tuesday] of a Policy Forum article discussing integration in research, policy, and practice." According to the Q&A, Collins discusses "[w]hy the integration of mental health care is so important," her "main motivations for initiating the series," and "the main barriers to moving this field forward," among other topics (4/30).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Balancing efficacy and safety: The challenges of mRNA drugs and vaccines in modern medicine